Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder

  • Author: Frederick L. Altice, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 2/5/20 (What's New)

Summary

  • D-lysergic acid diethylamide (LSD or acid) is a powerful hallucinogen[NIDA Club Drugs]
  • Short-term effects include increased heart rate, nausea, intensified feelings and sensory experiences, and changes in sense of time, and longer-term effects include speech problems, memory loss, weight loss, anxiety, depression, and suicidal thoughts[NIDA Club Drugs]

Action required

Keywords: Initial Antiretroviral Therapy, IV Drug Use, Special Populations

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.